Free Trial

Biora Therapeutics (BIOR) SEC Filings & 10K Form

Biora Therapeutics logo
$0.14 -0.01 (-5.00%)
As of 05/20/2025

Recent Biora Therapeutics SEC Filings

DateFilerForm TypeView
03/26/2025
8:30 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SCHEDULE 13D/A
12/30/2024
7:07 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
6:32 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:00 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
9:01 AM
Biora Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
10/29/2024
3:43 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:37 AM
Biora Therapeutics (Filer)
Form 424B5
10/29/2024
7:28 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:15 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:19 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:21 AM
Biora Therapeutics (Filer)
Form 424B3
10/29/2024
7:24 AM
Biora Therapeutics (Filer)
Form 424B3
10/23/2024
4:24 PM
Biora Therapeutics (Filer)
Form DEF 14A
10/11/2024
3:52 PM
Biora Therapeutics (Filer)
Form PRE 14A
10/11/2024
7:00 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:40 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
09/16/2024
3:30 PM
Biora Therapeutics (Filer)
Form DEF 14A
09/13/2024
9:37 AM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
09/05/2024
5:02 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
09/03/2024
3:31 PM
Biora Therapeutics (Filer)
Form PRE 14A
08/23/2024
4:06 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:08 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:11 PM
Biora Therapeutics (Filer)
Form 424B5
08/23/2024
4:13 PM
Biora Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/23/2024
4:03 PM
Biora Therapeutics (Filer)
Form 424B5
08/21/2024
4:00 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:15 PM
Biora Therapeutics (Subject)
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
Form SC 13G
08/14/2024
8:57 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
8:58 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
08/12/2024
3:30 PM
Biora Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:15 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:05 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
8:42 PM
Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
Form SC 13D/A
07/08/2024
8:15 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
8:00 PM
Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
7:21 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
5:04 AM
Biora Therapeutics (Filer)
Form 424B5
07/01/2024
5:07 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:30 PM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:31 AM
Biora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Howe Jill Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Alter Jeffrey D. (Reporting)
Biora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:33 PM
Biora Therapeutics (Issuer)
Kotzin Brian L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
06/02/2024
11:15 PM
Biora Therapeutics (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BIOR) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners